Picture of Sinco Pharmaceuticals Holdings logo

6833 Sinco Pharmaceuticals Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapValue Trap

Annual cashflow statement for Sinco Pharmaceuticals Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2018
December 31st
C2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-2724313616799.3
Depreciation
Amortisation
Non-Cash Items17521.22.8432.48.67
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital193-84-10.599.4-44.1
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities106-9.5513730675.1
Capital Expenditures-1.15-0.555-49.5-23.5-52.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.476-1.992.640.795-66.6
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-1.63-2.54-46.8-22.7-119
Financing Cash Flow Items130115-62.9-30437
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-99.5156-170-97.135
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4.69144-811823.09